Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.

M.F. Leahy; J.F. Seymour; R.J. Hicks; J Turner

Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.

M.F. Leahy, J.F. Seymour, R.J. Hicks, J Turner

Research output: Chapter in Book/Conference paper › Conference paper

Original language	English
Title of host publication	Annals of Oncology
Editors	David J. Kerr
Place of Publication	Oxford United Kingdom
Publisher	Oxford University Press
Pages	155-156
Volume	16
Edition	Lugano, Switzerland
ISBN (Print)	09237534
Publication status	Published - 2005
Event	Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial. - Lugano, Switzerland Duration: 1 Jan 2005 → …

Conference

Conference	Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.
Period	1/01/05 → …

Cite this

Leahy, M.F. ; Seymour, J.F. ; Hicks, R.J. et al. / Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial. Annals of Oncology. editor / David J. Kerr. Vol. 16 Lugano, Switzerland. ed. Oxford United Kingdom : Oxford University Press, 2005. pp. 155-156

@inproceedings{a1a366b874a54e428a08e9fa7b964aa2,

title = "Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.",

author = "M.F. Leahy and J.F. Seymour and R.J. Hicks and J Turner",

year = "2005",

language = "English",

isbn = "09237534",

volume = "16",

pages = "155--156",

editor = "Kerr, {David J.}",

booktitle = "Annals of Oncology",

publisher = "Oxford University Press",

address = "United Kingdom",

edition = "Lugano, Switzerland",

note = "Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial. ; Conference date: 01-01-2005",

}

Leahy, MF, Seymour, JF, Hicks, RJ & Turner, J 2005, Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial. in DJ Kerr (ed.), Annals of Oncology. Lugano, Switzerland edn, vol. 16, Oxford University Press, Oxford United Kingdom, pp. 155-156, Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial., 1/01/05.

Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial. / Leahy, M.F.; Seymour, J.F.; Hicks, R.J. et al.
Annals of Oncology. ed. / David J. Kerr. Vol. 16 Lugano, Switzerland. ed. Oxford United Kingdom: Oxford University Press, 2005. p. 155-156.

Research output: Chapter in Book/Conference paper › Conference paper

TY - GEN

T1 - Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.

AU - Leahy, M.F.

AU - Seymour, J.F.

AU - Hicks, R.J.

AU - Turner, J

PY - 2005

Y1 - 2005

M3 - Conference paper

SN - 09237534

VL - 16

SP - 155

EP - 156

BT - Annals of Oncology

A2 - Kerr, David J.

PB - Oxford University Press

CY - Oxford United Kingdom

T2 - Radioimmunotherapy with Iodine-131 anti-CD 20 chimeric monoclonal antigocy (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: results of an Australia phase II trial.

Y2 - 1 January 2005

ER -